944 related articles for article (PubMed ID: 16847063)
1. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease.
Anderson JP; Walker DE; Goldstein JM; de Laat R; Banducci K; Caccavello RJ; Barbour R; Huang J; Kling K; Lee M; Diep L; Keim PS; Shen X; Chataway T; Schlossmacher MG; Seubert P; Schenk D; Sinha S; Gai WP; Chilcote TJ
J Biol Chem; 2006 Oct; 281(40):29739-52. PubMed ID: 16847063
[TBL] [Abstract][Full Text] [Related]
2. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
Muntané G; Ferrer I; Martinez-Vicente M
Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
[TBL] [Abstract][Full Text] [Related]
3. Proteomics analysis identifies phosphorylation-dependent alpha-synuclein protein interactions.
McFarland MA; Ellis CE; Markey SP; Nussbaum RL
Mol Cell Proteomics; 2008 Nov; 7(11):2123-37. PubMed ID: 18614564
[TBL] [Abstract][Full Text] [Related]
4. Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.
Walker DG; Lue LF; Adler CH; Shill HA; Caviness JN; Sabbagh MN; Akiyama H; Serrano GE; Sue LI; Beach TG;
Exp Neurol; 2013 Feb; 240():190-204. PubMed ID: 23201181
[TBL] [Abstract][Full Text] [Related]
5. Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.
Bhattacharjee P; Öhrfelt A; Lashley T; Blennow K; Brinkmalm A; Zetterberg H
J Proteome Res; 2019 May; 18(5):2109-2120. PubMed ID: 30943367
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
[TBL] [Abstract][Full Text] [Related]
7. Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.
Fayyad M; Erskine D; Majbour NK; Vaikath NN; Ghanem SS; Sudhakaran IP; Abdesselem H; Lamprokostopoulou A; Vekrellis K; Morris CM; Attems J; El-Agnaf OMA
Brain Pathol; 2020 Jul; 30(4):831-843. PubMed ID: 32324926
[TBL] [Abstract][Full Text] [Related]
8. Pathological biochemistry of alpha-synucleinopathy.
Iwatsubo T
Neuropathology; 2007 Oct; 27(5):474-8. PubMed ID: 18018483
[TBL] [Abstract][Full Text] [Related]
9. α-Synuclein posttranslational modification and alternative splicing as a trigger for neurodegeneration.
Beyer K; Ariza A
Mol Neurobiol; 2013 Apr; 47(2):509-24. PubMed ID: 22923347
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
[TBL] [Abstract][Full Text] [Related]
11. Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies.
Martinez-Valbuena I; Amat-Villegas I; Valenti-Azcarate R; Carmona-Abellan MDM; Marcilla I; Tuñon MT; Luquin MR
Acta Neuropathol; 2018 Jun; 135(6):877-886. PubMed ID: 29536165
[TBL] [Abstract][Full Text] [Related]
12. [Clinical and pathological study on early diagnosis of Parkinson's disease and dementia with Lewy bodies].
Orimo S
Rinsho Shinkeigaku; 2008 Jan; 48(1):11-24. PubMed ID: 18386627
[TBL] [Abstract][Full Text] [Related]
13. LRP10 and α-synuclein transmission in Lewy body diseases.
Carreras Mascaro A; Grochowska MM; Boumeester V; Dits NFJ; Bilgiҫ EN; Breedveld GJ; Vergouw L; de Jong FJ; van Royen ME; Bonifati V; Mandemakers W
Cell Mol Life Sci; 2024 Feb; 81(1):75. PubMed ID: 38315424
[TBL] [Abstract][Full Text] [Related]
14. Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice.
Tanji K; Mori F; Mimura J; Itoh K; Kakita A; Takahashi H; Wakabayashi K
Acta Neuropathol; 2010 Aug; 120(2):145-54. PubMed ID: 20339856
[TBL] [Abstract][Full Text] [Related]
15. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies selective for α-synuclein oligomers/protofibrils recognize brain pathology in Lewy body disorders and α-synuclein transgenic mice with the disease-causing A30P mutation.
Fagerqvist T; Lindström V; Nordström E; Lord A; Tucker SM; Su X; Sahlin C; Kasrayan A; Andersson J; Welander H; Näsström T; Holmquist M; Schell H; Kahle PJ; Kalimo H; Möller C; Gellerfors P; Lannfelt L; Bergström J; Ingelsson M
J Neurochem; 2013 Jul; 126(1):131-44. PubMed ID: 23363402
[TBL] [Abstract][Full Text] [Related]
17. Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.
Colom-Cadena M; Pegueroles J; Herrmann AG; Henstridge CM; Muñoz L; Querol-Vilaseca M; Martín-Paniello CS; Luque-Cabecerans J; Clarimon J; Belbin O; Núñez-Llaves R; Blesa R; Smith C; McKenzie CA; Frosch MP; Roe A; Fortea J; Andilla J; Loza-Alvarez P; Gelpi E; Hyman BT; Spires-Jones TL; Lleó A
Brain; 2017 Dec; 140(12):3204-3214. PubMed ID: 29177427
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.
Miners JS; Renfrew R; Swirski M; Love S
Acta Neuropathol Commun; 2014 Dec; 2():164. PubMed ID: 25476568
[TBL] [Abstract][Full Text] [Related]
19. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
20. Familial Parkinson disease mutations influence α-synuclein assembly.
Ono K; Ikeda T; Takasaki J; Yamada M
Neurobiol Dis; 2011 Sep; 43(3):715-24. PubMed ID: 21684335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
